ALEXANDRA DE LELLIS: Open Payments
NPI 1730877895 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$361 in 19 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $379 · 2025 $361
Food & beverage: $361
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 4 | $62 |
| Sequel Med Tech, LLC | 3 | $52 |
| BETA BIONICS, INC. | 2 | $51 |
| Abbott Laboratories | 2 | $42 |
| Tandem Diabetes Care, Inc. | 2 | $29 |
| Averitas Pharma Inc. | 1 | $25 |
| SANOFI-AVENTIS U.S. LLC | 1 | $23 |
| Ascensia Diabetes Care Us Inc. | 1 | $21 |
| Mannkind Corporation | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
Products named: GVOKE HYPOPEN, TWIIST, iLet Bionic Pancreas, FREESTYLE LIBRE 3, t:slim X2 Insulin Pump with Control-IQ, QUTENZA, TZIELD, AFREZZA.
Industry payments across IN — which companies pay providers there.
